To investigate whether long‐term sorafenib treatment induced CSC differentiation in HCC cultures, we analysed the expression of the cell membrane protein CD133, which was recently identified as a stem cell marker in HCC (Castelli et al., 2017). Here, PROM1 is linked to hepatocellular carcinoma.